(Q51482308)

5 April 2018

title

The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro. (English)

1 reference

5 April 2018

1 reference

Arasaki K

1

1 reference

5 April 2018

Kusunoki S

series ordinal

2

1 reference

5 April 2018

Kudo N

series ordinal

3

1 reference

5 April 2018

Tamaki M

series ordinal

4

1 reference

5 April 2018

publication date

1 December 1998

1 reference

5 April 2018

Journal of the Neurological Sciences

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

5 April 2018

volume

161

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

163-168

1 reference

5 April 2018

Acute conduction block in vitro following exposure to antiganglioside sera.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Experimental sensory neuropathy induced by sensitization with ganglioside GD1b.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Binding of antibodies against GM1 and GD1b in human peripheral nerve.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Do GM1 antibodies induce demyelination?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Multifocal motor neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Experimental conduction block induced by serum from a patient with anti-GM1 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900283-4

10.1016/S0022-510X(98)00283-4

7 January 2021

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

9879698

1 reference

5 April 2018